Skip to main content

Taxotere Risk of Permanent Hair Loss Withheld from Women and Doctors, Lawsuit Alleges

bigcolums_ss_170748863

As more women learn about the link between Taxotere and permanent hair loss, a growing number of product liability lawsuits are being filed against the manufacturer of the breast cancer chemotherapy drug, alleging that patients and the medical community were not adequately warned that hair does not regrow for many women.

A complaint filed last week in the U.S. District Court for the Western District of Texas, raises similar claims to those presented in other cases filed by women throughout the U.S. in recent months who have experienced permanent hair loss after undergoing breast cancer treatment involving use of the controversial Sanofi-Aventis drug.

The lawsuit was filed by Alina S. Gorniak, alleging that breast cancer patients and the medical community have been provided false and misleading information about the Taxotere risk of permanent hair loss, depriving them of the opportunity to make an informed decision about whether to use the drug over other available chemotherapy drugs.

Gorniak indicates that she was diagnosed with infiltrating ductal carcinoma of the left breast in January 2013, and she was given Taxotere as part of chemotherapy before undergoing a surgical resection of her left breast. Although Sanofi-Aventis suggested that hair typically regrows following treatment with their drug, Gorniak claims that she has suffered permanent and disfiguring hair problems from Taxotere, known as alopecia, mirroring similar claims raised by other women who received the drug.

Taxotere (docetaxel) was approved by the FDA in May 1996, as a more potent version of another breast cancer treatment that was already on the market. Despite claims by the drug maker that Taxotere was superior to lower potency taxane-based drugs, Gorniak and other plaintiffs allege that it is actually no more effective than the earlier treatment options, yet carries a high risk that users may be left with permanent hair problems; a risk that is not associated with other breast cancer drugs.

"Defendants knew or should have known that the rate of permanent alopecia related to Taxotere was far greater than with other products available to treat the same condition as Defendants' product," the lawsuit states. "Before Defendants' wrongful conduct resulted in thousands of women being exposed to the side effects of Taxotere, there were already similar products on the market that were at least as effective as Taxotere and did not subject female users to the same risk of disfiguring permanent alopecia as does Taxotere."

The lawsuit notes that Sanofi knew of the risks since the beginning of the 1990s. In addition, Gorniak and other women point to a 2005 study conducted by the drug maker, known as GEICAM 9805, which found that 9.2% of patients who took Taxotere suffered hair loss that lasted up to 10 years and five months, and in some cases longer. In 2006, a Denver oncologist also warned the manufacturer that 6.3% of his patients suffered long-term or permanent hair loss after Taxotere treatment.

The cases point out that while women may have accepted the Taxotere risk of permanent hair loss if no other treatment options were available, this was not the case, as similar drugs on the market at the time Taxotere was introduced provided the same treatment benefits without subjecting female users to the same risk of hair loss.

"Permanent baldness (permanent alopecia) is a disfiguring condition, especially for women," claims Gorniak in the complaint filed May 31. "Women who experience disfiguring permanent alopecia as a result of the use of Taxotere suffer great mental anguish as well as economic damages, including but not limited to loss of work or inability to work due to significant psychological damage."

Gorniak presents claims of negligence, design and manufacturing defects, failure to warn, breach of warranty, fraudulent misrepresentation, fraudulent concealment, negligent misrepresentation, fraud and deceit, violation of Texas consumer protection laws, and extreme and outrageous conduct.

Tags: Alopecia, Breast Cancer, Chemotherapy, Hair Loss, Sanofi-Aventis, Taxotere


Source: Taxotere Risk of Permanent Hair Loss Withheld from Women and Doctors, Lawsuit Alleges

Comments

Popular Posts

How Long Does Postpartum Hair Loss Last?

After you have a baby, there's hardly time for yourself. Showers are few and far between, meals are generally eaten while standing in the kitchen, and fixing your hair is out of the question. But while your hair is probably the last thing on your mind, it is part of an issue that not enough people talk about: postpartum hair loss. Dr. Heather Hawthorne, MD and board-certified family physician at Doctor On Demand, spoke to POPSUGAR about postpartum hair loss, which affects a lot more women than most people realise. What Is Postpartum Hair Loss? During pregnancy, a lot of women may start to feel like Rapunzel due to their hair growing so fast and strong that you feel it could hoist a handsome prince up a tower (wouldn't that be great?). "Many women notice longer, more voluminous hair during pregnancy thanks to pregnancy hormone spikes trapping hair in the growth (anagen) phase of the hair cycle," Dr. Hawthorne explained. "But drastic postpartum hormone shi

A Breakthrough for Hair Loss! PGD2 and Natural Ways to Regrow Your Hair

In 2012, the dermatology departments of the University of Pennsylvania and Johns Hopkins University generated a lot of buzz around a potential "miracle cure" for baldness. The big discovery? A relationship between prostaglandin D2 (a fatty acid derivative) and male pattern baldness, and hair loss in women. The researchers demonstrated, for the first time in humans, that a lipid derivative called prostaglandin D2 was elevated in balding areas – but not in hair-bearing areas – of men with hair loss. More importantly, they also discovered that prostaglandin D2 inhibits hair lengthening. The more prostaglandin D2 present, the shorter a hair grows. The team suggested that by maybe inhibiting prostaglandin D2 in the scalp, hair loss might be stopped. And that got a lot of hair loss sufferers (and pharmaceutical companies) excited. Prostaglandin-D2 inhibitors were already in trials as a treatment for asthma. It wouldn't be hard to develop a topical for men&#

Best Hair Regrowth Treatments Available in the Market

Hello, buddies! Hope everything is going good at your end! I am super excited about today's post because it will surely help thousands of people dealing with the problem. Hair fall is one among the most common problems every one of us suffers from. From unhygienic hair condition to hormonal issues and genetic problems, there are many reasons behind the hair fall of a person. Regardless of origin and ethnicity, baldness is a condition that affects the majority of the population. The only upside to this is that there are many treatments available in the market which can help to treat this issue. From laser treatments to taking proper medicines, there are many treatments that can help in the hair regrowth. Check out the best hair regrowth treatments available. 1. Laser Treatments: Laser treatment is quite common, popular and effective hair growth treatment available in the market which gives you guaranteed results. Laser treatments can help to prevent hair

Fue hair transplant: a confirmed answer of hair loss

It has been noticed that most people of individuals are afraid to brush their hair simply due to hair loss. The ratio of sufferers of hair loss is increasing day-by-day. In case your hair fall is restrained to one hundred strands on day by day foundation then it isn't always an issue. However if it exceeds then it's far an problem that desires to be resolved. This is referred to as the global widespread, however, there can be some underline causes of hair loss. If you are dealing with intense hair loss then hair transplant would be the quality choice for you. Fue hair transplant Fue hair transplant is considered as a only remedy to get a everlasting approach to your hair loss. The fashion of hair healing greater in human beings with the passage of time. The improvements of technology carry focus amongst people regarding data of hair transplant. Fue hair remedy well-knownshows more high-quality outcomes at the bald region of guys as compared to women. The motive is

6 Ways to Stop Hair Loss, According to Science

Here are the best ways to keep what you've got. (Getty) Statistics show that by the age of 35, around 66 percent of men lose a considerable amount of hair, and by 55, 85 percent of men have significant hair loss...by which I mean bald or balding. I'm really sorry, but that means there's a giant chance you're either going to go completely bald, or at least partially.  And even though it's not the end of the world if (or when) you lose your hair, it's certainly not pleasant to go through, and it can take a huge shit on your self-esteem. Life is mean, isn't it? However, if it's any consolation, it's actually been scientifically proven that women totally dig bald dudes and get all hot in the panties for them, because they see baldies as smarter, more dominant, and overall way sexier than men who still have a perfect head of hair.  But if that's not enough solace to make you come to terms with going bald, there are some science-backed ways to try a